Market Tracker

06/23 5:16pm ET

Exelixis Inc (NASDAQ:EXEL)

23.78
Delayed Data
As of Jun 23
 -0.29 / -1.20%
Today’s Change
7.20
Today|||52-Week Range
24.85
+59.49%
Year-to-Date

Today’s Trading

Previous close24.07
Today’s open24.11
Day’s range23.78 - 24.54
Volume31,692,494
Average volume (3 months)4,176,345
Market cap$7.0B
Dividend yield--
Data as of 4:14pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+65.43%
Earnings growth (this year)+165.08%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+415.05%
P/E ratio792.7
Price/Sales19.51
Price/Book77.19

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC-0.26-0.27%
CRLCharles River Labora...-0.12-0.12%
PRAHPRA Health Sciences ...+0.28+0.37%
PRXLPAREXEL Internationa...-0.31-0.36%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.04
Annual revenue (last year)$191.5M
Annual profit (last year)-$70.2M
Net profit margin-36.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Executive VP, Chief Financial &
Accounting Officer
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts